Robert A Burger

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Robert S Mannel, R. Burger, R. Ozols, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.

Howard Mackey, R. Burger, R. Wenham, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overview of anti-angiogenic agents in development for ovarian cancer.

R. Burger, Robert A Burger, 2011, Gynecologic oncology.

Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.

B. Monk, R. Burger, S. Rubin, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

R. Burger, Joan L. Walker, D. Armstrong, 2006, The New England journal of medicine.

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.

Michael W Sill, B. Monk, R. Burger, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

B. Monk, R. Burger, J. Kuo, 2009, Gynecologic oncology.

Inherited Mutations in Women With Ovarian Carcinoma.

Tom Walsh, Nilsa C Ramirez, Robert S Mannel, 2016, JAMA oncology.

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.

R. Burger, J. Thigpen, M. Brady, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer.

R. Burger, M. Brady, M. Bookman, 2013, Gynecologic oncology.

Epithelial ovarian cancer.

Ardeshir Hakam, Paul Sabbatini, P. Grigsby, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.